Hostname: page-component-89b8bd64d-46n74 Total loading time: 0 Render date: 2026-05-06T10:24:46.938Z Has data issue: false hasContentIssue false

The Oxford Agoraphobic Avoidance Scale

Published online by Cambridge University Press:  23 August 2021

Sinead Lambe*
Affiliation:
Department of Psychiatry, University of Oxford, Oxford, UK Oxford Health NHS Foundation Trust, Oxford, UK NIHR Oxford Health Biomedical Research Centre, Oxford, UK
Jessica C. Bird
Affiliation:
Department of Psychiatry, University of Oxford, Oxford, UK Oxford Health NHS Foundation Trust, Oxford, UK
Bao Sheng Loe
Affiliation:
The Psychometrics Centre, University of Cambridge, Cambridge, UK
Laina Rosebrock
Affiliation:
Department of Psychiatry, University of Oxford, Oxford, UK Oxford Health NHS Foundation Trust, Oxford, UK NIHR Oxford Health Biomedical Research Centre, Oxford, UK
Thomas Kabir
Affiliation:
The McPin Foundation, London, UK
Ariane Petit
Affiliation:
Department of Psychiatry, University of Oxford, Oxford, UK Oxford Health NHS Foundation Trust, Oxford, UK NIHR Oxford Health Biomedical Research Centre, Oxford, UK
Sophie Mulhall
Affiliation:
Department of Psychiatry, University of Oxford, Oxford, UK Oxford Health NHS Foundation Trust, Oxford, UK
Lucy Jenner
Affiliation:
Department of Psychiatry, University of Oxford, Oxford, UK Oxford Health NHS Foundation Trust, Oxford, UK
Charlotte Aynsworth
Affiliation:
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK
Elizabeth Murphy
Affiliation:
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK
Julia Jones
Affiliation:
Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK
Rosie Powling
Affiliation:
Avon and Wiltshire Mental Health Partnership NHS Trust, Bath, UK
Kate Chapman
Affiliation:
Avon and Wiltshire Mental Health Partnership NHS Trust, Bath, UK
Robert Dudley
Affiliation:
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK Newcastle University, Newcastle upon Tyne, UK
Anthony Morrison
Affiliation:
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK Division of Psychology and Mental Health, University of Manchester, Manchester, UK
Eileen O. Regan
Affiliation:
Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK
Ly-Mee Yu
Affiliation:
Primary Care Clinical Trials Unit, Nuffield Department of Primary care Health Sciences, University of Oxford, Oxford, UK
David Clark
Affiliation:
Oxford Health NHS Foundation Trust, Oxford, UK NIHR Oxford Health Biomedical Research Centre, Oxford, UK Department of Experimental Psychology, University of Oxford, Oxford, UK
Felicity Waite
Affiliation:
Department of Psychiatry, University of Oxford, Oxford, UK Oxford Health NHS Foundation Trust, Oxford, UK NIHR Oxford Health Biomedical Research Centre, Oxford, UK
Daniel Freeman
Affiliation:
Department of Psychiatry, University of Oxford, Oxford, UK Oxford Health NHS Foundation Trust, Oxford, UK NIHR Oxford Health Biomedical Research Centre, Oxford, UK
*
Author for correspondence: Sinead Lambe, E-mail: Sinead.lambe@psych.ox.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Background

Agoraphobic avoidance of everyday situations is a common feature in many mental health disorders. Avoidance can be due to a variety of fears, including concerns about negative social evaluation, panicking, and harm from others. The result is inactivity and isolation. Behavioural avoidance tasks (BATs) provide an objective assessment of avoidance and in situ anxiety but are challenging to administer and lack standardisation. Our aim was to draw on the principles of BATs to develop a self-report measure of agoraphobia symptoms.

Method

The scale was developed with 194 patients with agoraphobia in the context of psychosis, 427 individuals in the general population with high levels of agoraphobia, and 1094 individuals with low levels of agoraphobia. Factor analysis, item response theory, and receiver operating characteristic analyses were used. Validity was assessed against a BAT, actigraphy data, and an existing agoraphobia measure. Test–retest reliability was assessed with 264 participants.

Results

An eight-item questionnaire with avoidance and distress response scales was developed. The avoidance and distress scales each had an excellent model fit and reliably assessed agoraphobic symptoms across the severity spectrum. All items were highly discriminative (avoidance: a = 1.24–5.43; distress: a = 1.60–5.48), indicating that small increases in agoraphobic symptoms led to a high probability of item endorsement. The scale demonstrated good internal reliability, test–retest reliability, and validity.

Conclusions

The Oxford Agoraphobic Avoidance Scale has excellent psychometric properties. Clinical cut-offs and score ranges are provided. This precise assessment tool may help focus attention on the clinically important problem of agoraphobic avoidance.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re- use, distribution and reproduction, provided the original article is properly cited.
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press
Figure 0

Table 1. Participant demographics and clinical characteristics

Figure 1

Table 2. Factor loadings for the O-AS distress scale from EFA derivation sample (n = 621) and Factor loadings for the O-AS distress and avoidance scales from CFA in full sample (N = 1715)

Figure 2

Table 3. Discrimination (a) and difficulty (b) item parameters for O-AS avoidance and distress scales

Figure 3

Fig. 1. Test information

Figure 4

Table 4. Mean scores and proportions of participants scoring above each score range for the three participant groups

Figure 5

Table 5. Descriptive statistics and bivariate correlations between the O-AS and the other measures in the total sample, the general population (split into low and high agoraphobia subgroups), and patients with psychosis and agoraphobia

Supplementary material: File

Lambe et al. supplementary material

Lambe et al. supplementary material

Download Lambe et al. supplementary material(File)
File 435.4 KB